Global Pharmaceutical Company Commits to a Dual-Site Deal with AGC Biologics Exceeding €0.5 Billion
The 19,000 m² manufacturing building at AGC Biologics’ Copenhagen, Denmark site The expanded deal calls for multi-product drug…
Browsing Tag